These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25275271)

  • 1. LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial.
    Steinberg WM; Nauck MA; Zinman B; Daniels GH; Bergenstal RM; Mann JF; Steen Ravn L; Moses AC; Stockner M; Baeres FM; Marso SP; Buse JB;
    Pancreas; 2014 Nov; 43(8):1223-31. PubMed ID: 25275271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial.
    Steinberg WM; Buse JB; Ghorbani MLM; Ørsted DD; Nauck MA; ;
    Diabetes Care; 2017 Jul; 40(7):966-972. PubMed ID: 28476871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program.
    Steinberg WM; Rosenstock J; Wadden TA; Donsmark M; Jensen CB; DeVries JH
    Diabetes Care; 2017 Jul; 40(7):839-848. PubMed ID: 28473337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide-associated acute pancreatitis.
    Knezevich E; Crnic T; Kershaw S; Drincic A
    Am J Health Syst Pharm; 2012 Mar; 69(5):386-9. PubMed ID: 22345417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting.
    Lando HM; Alattar M; Dua AP
    Endocr Pract; 2012; 18(4):472-7. PubMed ID: 22440997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pancreatitis associated with liraglutide.
    Lee PH; Stockton MD; Franks AS
    Ann Pharmacother; 2011 Apr; 45(4):e22. PubMed ID: 21487080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial.
    Marso SP; Poulter NR; Nissen SE; Nauck MA; Zinman B; Daniels GH; Pocock S; Steinberg WM; Bergenstal RM; Mann JF; Ravn LS; Frandsen KB; Moses AC; Buse JB
    Am Heart J; 2013 Nov; 166(5):823-30.e5. PubMed ID: 24176437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis.
    Vrang N; Jelsing J; Simonsen L; Jensen AE; Thorup I; Søeborg H; Knudsen LB
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E253-64. PubMed ID: 22589391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with DPP-4 inhibitors does not increase the chance of pancreatitis in patients with type 2 diabetes.
    Shetty AS; Nandith A; Snehalath C; Ramachandran A
    J Assoc Physicians India; 2013 Aug; 61(8):543-4. PubMed ID: 24818338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.
    Hermansen K; Bækdal TA; Düring M; Pietraszek A; Mortensen LS; Jørgensen H; Flint A
    Diabetes Obes Metab; 2013 Nov; 15(11):1040-8. PubMed ID: 23683069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer.
    Chalmer T; Almdal TP; Vilsbøll T; Knop FK
    Expert Opin Drug Saf; 2015 Jan; 14(1):171-80. PubMed ID: 25363438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial.
    Nauck MA; Muus Ghorbani ML; Kreiner E; Saevereid HA; Buse JB;
    Diabetes Care; 2019 Oct; 42(10):1912-1920. PubMed ID: 31399438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide and Renal Outcomes in Type 2 Diabetes.
    Mann JFE; Ørsted DD; Brown-Frandsen K; Marso SP; Poulter NR; Rasmussen S; Tornøe K; Zinman B; Buse JB;
    N Engl J Med; 2017 Aug; 377(9):839-848. PubMed ID: 28854085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amylase and lipase in the evaluation of acute abdominal pain.
    Chase CW; Barker DE; Russell WL; Burns RP
    Am Surg; 1996 Dec; 62(12):1028-33. PubMed ID: 8955242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations.
    Daniels GH; Hegedüs L; Marso SP; Nauck MA; Zinman B; Bergenstal RM; Mann JF; Derving Karsbøl J; Moses AC; Buse JB; Tuttle RM;
    Diabetes Obes Metab; 2015 May; 17(5):477-86. PubMed ID: 25656058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.
    Petrie JR; Marso SP; Bain SC; Franek E; Jacob S; Masmiquel L; Leiter LA; Haluzik M; Satman I; Omar M; Shestakova M; Van Gaal L; Mann JF; Baeres FM; Zinman B; Poulter NR;
    J Hypertens; 2016 Jun; 34(6):1140-50. PubMed ID: 26855018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus.
    Aughsteen AA; Abu-Umair MS; Mahmoud SA
    Saudi Med J; 2005 Jan; 26(1):73-7. PubMed ID: 15756357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of amylase and lipase levels of patients with Type 2 diabetes under different treatment modalities.
    Cakmak R; Caklili OT; Tekin S; Hacisahinogullari H; Tanrikulu S; Koc MS; Dinccag N
    Biomark Med; 2022 Jan; 16(1):5-10. PubMed ID: 34856813
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.
    Armstrong MJ; Houlihan DD; Rowe IA; Clausen WH; Elbrønd B; Gough SC; Tomlinson JW; Newsome PN
    Aliment Pharmacol Ther; 2013 Jan; 37(2):234-42. PubMed ID: 23163663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.